Home » EPIC Archives: OXB

OXB News Archives



Follow this company OXB
X

Follow this company OXB

E-mail : *
* Your personal data will be used to support your experience throughout this website and for other purposes described in our Privacy Policy. I hereby agree and consent to the privacy policy.

Oxford BioMedica Eying up long-term value

Hardman & Co

Oxford BioMedica (OXB) is a specialist, advanced therapy, viral-vector biopharma company. It offers vector manufacturing and development services, while developing proprietary drug candidates, with its LentiVector® platform. 2018 saw significant ...

Read Article »

Oxford BioMedica De-leveraging the balance sheet

Hardman & Co

Oxford BioMedica (LON: OXB) is a specialist, advanced therapy, viral-vector biopharma company. It offers vector manufacturing and development services, while developing proprietary drug candidates, with its LentiVector® platform. 2018 saw ...

Read Article »

Partnering strategy delivering profitability

Hardman & Co

Oxford BioMedica (LON:OXB) is a specialist advanced therapy viral-vector biopharmaceutical company. It offers vector manufacturing and development services, while retaining proprietary drug candidates. OXB will also receive royalties on commercial ...

Read Article »